Transition Services for Paediatric Inflammatory Bowel Disease: A Multicentre Study of Practice in the United Kingdom

James J Ashton1,2, Priya Narula3, Fevronia Kiparissi4

  • 1Department of Paediatric Gastroenterology, Southampton Children's Hospital.

Insights

This UK study found that while most paediatric inflammatory bowel disease (IBD) centres initiate transition care by age 16, resources like dietetic and psychological support are inconsistently available, highlighting a need for standardized services.

Area of Science:

  • Paediatric gastroenterology
  • Inflammatory Bowel Disease (IBD) management
  • Healthcare transition services

Background:

  • Paediatric inflammatory bowel disease (IBD) patients represent a significant cohort requiring transfer from pediatric to adult healthcare services.
  • Standardized transition care is crucial for optimizing both short-term and long-term patient outcomes.
  • This study addresses the need to understand the current landscape of transition services for IBD in the United Kingdom (UK).

Purpose of the Study:

  • To detail the current status of transition services for paediatric inflammatory bowel disease (IBD) patients across the UK.
  • To identify existing practices, available resources, and facilities within specialist IBD centres.
  • To gather data that can inform the development of a national strategy for improving transition care.

Main Methods:

  • A nationwide study was conducted involving specialist paediatric IBD centres in the UK.
  • Data were collected from 20 out of 21 invited centres (95% response rate).
  • Information gathered included timing of transition, available transition resources (clinics, staff, patient information), and future improvement plans.

Main Results:

  • Transition typically begins before age 16, with transfer to adult care completed by age 18 in all responding centres.
  • Joint clinics involving adult and paediatric gastroenterologists are universal, averaging 12.9 per year.
  • Availability of essential support staff (dietitians, psychologists, surgeons) is inconsistent (<50% of centres), and key health topics are not always discussed (<60% discuss sexual health, contraception, pregnancy).

Conclusions:

  • The study provides crucial real-world data on UK-wide transition services for paediatric IBD.
  • Findings highlight variability in resource availability and service provision.
  • The data can guide the development of a national strategy to standardize IBD transition care while allowing for local adaptation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
482
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
285
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
274
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
276
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
304
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
553